- Price
- $104.42
- Day
- -0.90%
- Mkt Cap
- $133.23B
- 52W Range
- $61.35 – $110.68
- Volume
- 5.63M
- Beta
- 0.60
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read full article
CVS heads into Q2 earnings with estimates pointing to revenue and EPS growth as Aetna initiatives and key business segments support results.
Read full article
Stock futures are pointing to a higher open to kick off August trading as investors look ahead to a packed week of earnings reports; oil prices are tumbling after the U.S. paused strikes on Iran over the weekend; SpaceX is due to reports earnings for the first time this week, headlining a busy week of corporate results; Palantir is scheduled to release its earnings report after the closing bell today; and shares of AstraZeneca and Bristol-Myers Squibb are moving sharply following a report that the pharmaceutical giants have discussed a potential merger. Here's what you need to know today.
Read full article
Millions of Medicare Advantage members will open a letter this fall that could quietly close doors they assume will always stay open. What insurers have already decided for 2027 and what enrollees do next could cost thousands of dollars or make coverage impossible to find.
Read full article
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read full article
Beyond analysts' top-and-bottom-line estimates for CVS Health (CVS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.
Read full article
The enterprise earned the program's top honor plus gold recognition in AI innovation, measurement excellence, employee engagement, and consumer-centric culture WOONSOCKET, R.I., July 30, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that it has been named Overall Winner and earned four gold awards at the 2026 US Customer Experience Awards (USCXA26), the country's premier independent recognition program for CX excellence.
Read full article
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read full article
CVS Health (CVS) closed the most recent trading day at $109.34, moving +2.12% from the previous trading session.
Read full article
Entropy Technologies LP purchased a new stake in shares of CVS Health Corporation (NYSE: CVS) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 28,146 shares of the pharmacy operator's stock, valued at approximately $2,021,000. A number of other
Read full article
CVS, CAH, HUM and ACAD look ready for Q2 2026 earnings beats as growing demand for medical products and services continues to support performance.
Read full article
CVS Health (NYSE:CVS | CVS Price Prediction) shares closed at $106.89 on July 23, 2026, up 78.2% over the past year.
Read full article